Brain malformation in single median maxillary central incisor

Autor: K. Holm, Aa. Wagner, L. L. Thomsen, I. Kjær

Publikováno v: Neuropediatrics. 40(6)

Clinical and radiographic examinations and MR scan of a 12-year-old girl with SMMCI (single median maxillary central incisor) showed impaired growth and a midline defect involving the central incisor, cranium and the midline structures in the brain,

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::702c3f3dd1d558c31d5dca026713d912
https://pubmed.ncbi.nlm.nih.gov/20446222

Hyperplastic Callus Formation in Osteogenesis Imperfecta

Autor: A. -J. Burchardt, AA. Wagner, P. Basse

Publikováno v: Acta Radiologica. 35:426-428

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e76e57f217edaf16ccb0ede8d089096e
https://doi.org/10.3109/02841859409174329

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Long-Term Outcomes in Patients Using Protocol-Directed Active Surveillance for Prostate Cancer.

Autor: Newcomb LF; Cancer Prevention Program, Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, Washington.; Department of Urology, University of Washington, Seattle., Schenk JM; Cancer Prevention Program, Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, Washington., Zheng Y; Biostatistics Program, Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, Washington., Liu M; Biostatistics Program, Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, Washington., Zhu K; Biostatistics Program, Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, Washington., Brooks JD; Department of Urology, Stanford University, Stanford, California., Carroll PR; Department of Urology, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco., Dash A; Department of Urology, Veterans Affairs Puget Sound Health Care System, Seattle, Washington., de la Calle CM; Department of Urology, University of Washington, Seattle., Ellis WJ; Department of Urology, University of Washington, Seattle., Filson CP; Department of Urology, Emory University School of Medicine, Atlanta, Georgia.; Department of Urology, Kaiser Permanente, Los Angeles, California., Gleave ME; Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada., Liss MA; Department of Urology, University of Texas Health Sciences Center, San Antonio., Martin F; Department of Urology, Eastern Virginia Medical School, Virginia Beach., McKenney JK; Robert J. Tomsich Pathology & Laboratory Medicine Institute, Cleveland Clinic, Cleveland, Ohio., Morgan TM; Department of Urology, University of Michigan, Ann Arbor., Tretiakova MS; Department of Pathology, University of Washington, Seattle., Wagner AA; Division of Urology, Beth Israel Deaconess Medical Center, Boston, Massachusetts., Nelson PS; Division of Human Biology, Fred Hutchinson Cancer Center, Seattle, Washington., Lin DW; Cancer Prevention Program, Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, Washington.; Department of Urology, University of Washington, Seattle.

Publikováno v: JAMA [JAMA] 2024 Jun 25; Vol. 331 (24), pp. 2084-2093.

Postradical prostatectomy prostate-specific antigen outcomes after 6 versus 18 months of perioperative androgen-deprivation therapy in men with localized, unfavorable intermediate-risk or high-risk prostate cancer: Results of part 2 of a randomized phase 2 trial.

Autor: McKay RR; Department of Medicine, University of California San Diego, La Jolla, California, USA.; Department of Urology, University of California San Diego, La Jolla, California, USA., Xie W; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Yang X; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Acosta A; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA., Rathkopf D; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Laudone VP; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Bubley GJ; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Einstein DJ; Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA., Chang P; Department of Surgery, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA., Wagner AA; Department of Surgery, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA., Kane CJ; Department of Urology, University of California San Diego, La Jolla, California, USA., Preston MA; Department of Surgery, Brigham and Women's Hospital, Boston, Massachusetts, USA., Kilbridge K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Chang SL; Department of Surgery, Brigham and Women's Hospital, Boston, Massachusetts, USA., Choudhury AD; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Pomerantz MM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Trinh QD; Department of Surgery, Brigham and Women's Hospital, Boston, Massachusetts, USA., Kibel AS; Department of Surgery, Brigham and Women's Hospital, Boston, Massachusetts, USA., Taplin ME; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.

Publikováno v: Cancer [Cancer] 2024 May 01; Vol. 130 (9), pp. 1629-1641. Date of Electronic Publication: 2024 Jan 01.